Modern (MRNA) – Get report it increased after Jefferies analyst Michael Yee began coverage of the biopharmaceutical company with a buy rating and a stock price target of $ 90, and Nasdaq said it would add the shares to the Nasdaq 100. The company’s coronavirus vaccine candidate could sell for …
Read More »
A new study involving more than 92,000 COVID-19 patients in Brazil shows that the odds of serious illness, ventilatory support requirement, and death are reduced with a trivalent recent flu shot. This seems to indicate that these vaccines should be used as widely as possible to reduce the risk of …
Read More »
Moderna’s MRNA shares were lower after a news report said biotechnology was delaying the start of a Phase III trial of its experimental coronavirus vaccine. Shares of the Cambridge, Massachusetts company in the latest check fell 5.4% to $ 58.25. Healthcare website Stat News said Moderna was making changes to …
Read More »
Public health officials told a Senate committee Thursday that a panel of experts outside the United States government can help decide who gets the COVID-19 vaccine first. Dr. Francis Collins, Director of the National Institutes of Health, acknowledged that the public might be wary of the US government having the …
Read More »
Shares rose Thursday after results showed Pfizer announced positive results Wednesday for an early-stage vaccination trial. Pfizer said that patients created 1.8 to 2.8 times the antibodies seen in those who recovered from COVID-19. A market analyst said that the “V-shaped recovery gnomes, once again, are getting to heaven.” But …
Read More »